Education
About Us
Working with TipRanks
Follow Us
Biovica International AB Class B (DE:9II)
:9II
RESEARCH TOOLSreports
9II Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.03 - €0.26
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€6.22M
Enterprise ValueN/A
Total Cash (Recent Filing)€43.51M
Total Debt (Recent Filing)kr6.12M
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Jun 18, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding84,073,710
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)1.09
Price to Sales (P/S)0.00
P/FCF Ratio-0.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biovica International AB Class B News
9II FAQ
What was Biovica International AB Class B’s price range in the past 12 months?
Biovica International AB Class B lowest stock price was €0.03 and its highest was €0.26 in the past 12 months.
What is Biovica International AB Class B’s market cap?
Biovica International AB Class B’s market cap is €6.22M.
When is Biovica International AB Class B’s upcoming earnings report date?
Biovica International AB Class B’s upcoming earnings report date is Jun 18, 2025 which is in 20 days.
How were Biovica International AB Class B’s earnings last quarter?
Biovica International AB Class B released its earnings results on Mar 13, 2025. The company reported -€0.029 earnings per share for the quarter, missing the consensus estimate of -€0.026 by -€0.003.
Is Biovica International AB Class B overvalued?
According to Wall Street analysts Biovica International AB Class B’s price is currently Overvalued.
Does Biovica International AB Class B pay dividends?
Biovica International AB Class B does not currently pay dividends.
What is Biovica International AB Class B’s EPS estimate?
Biovica International AB Class B’s EPS estimate is -0.03.
How many shares outstanding does Biovica International AB Class B have?
Biovica International AB Class B has 84,073,710 shares outstanding.
What happened to Biovica International AB Class B’s price movement after its last earnings report?
Biovica International AB Class B reported an EPS of -€0.029 in its last earnings report, missing expectations of -€0.026. Following the earnings report the stock price went down -15.385%.
Which hedge fund is a major shareholder of Biovica International AB Class B?
Currently, no hedge funds are holding shares in DE:9II
Company Description
Biovica International AB Class B
Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.
Technical Analysis
Biosergen AB
―
Nanologica AB
―
Active Biotech AB
―
Spago Nanomedical AB
―
Bio-Works Technologies AB
―